share_log

博安生物:自願性公告創新ADC候選藥物BA1302在中國獲批開展臨床試驗

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTAPPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FORTHE NOVEL ADC CANDIDATE BA1302 IN CHINA

Hong Kong Stock Exchange ·  Jul 25 16:41

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.